Healios K.K
Healios K.K., together with its subsidiaries, engages in the research, development, manufacturing, and sale of cell therapy and regenerative medicine products in Japan, Europe, and the United States. The company offers HLCM051, which is preparing for approval for the treatment of acute respiratory distress syndrome; HLCM051, which is preparing for phase 3 clinical trial for the treatment of ische… Read more
Healios K.K (HLOSF) - Total Liabilities
Latest total liabilities as of December 2025: $12.17 Billion USD
Based on the latest financial reports, Healios K.K (HLOSF) has total liabilities worth $12.17 Billion USD as of December 2025.
Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
Healios K.K - Total Liabilities Trend (2014–2025)
This chart illustrates how Healios K.K's total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.
Healios K.K Competitors by Total Liabilities
The table below lists competitors of Healios K.K ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Forest Packaging Group Co Ltd
SHG:605500
|
China | CN¥1.62 Billion |
|
MK Electron Co. Ltd
KQ:033160
|
Korea | ₩1.48 Trillion |
|
Qijing Machinery
SHG:603677
|
China | CN¥1.08 Billion |
|
Enli Technology Co.,Ltd
TWO:7728
|
Taiwan | NT$156.84 Million |
|
Swedencare AB (publ)
OTCQX:SWDCF
|
USA | $2.85 Billion |
|
Crexendo Inc
NASDAQ:CXDO
|
USA | $13.87 Million |
|
Design Milk Co Limited
PINK:AHAHF
|
USA | $685.52K |
|
Black Spade Acquisition II Co
NASDAQ:BSII
|
USA | $6.81 Million |
Liability Composition Analysis (2014–2025)
This chart breaks down Healios K.K's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 2.00 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 2.49 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.71 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Healios K.K's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Healios K.K (2014–2025)
The table below shows the annual total liabilities of Healios K.K from 2014 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-12-31 | $12.17 Billion | +0.48% |
| 2024-12-31 | $12.11 Billion | +7.26% |
| 2023-12-31 | $11.29 Billion | +5.97% |
| 2022-12-31 | $10.65 Billion | -30.50% |
| 2021-12-31 | $15.33 Billion | +0.04% |
| 2020-12-31 | $15.32 Billion | +26.35% |
| 2019-12-31 | $12.12 Billion | +188.83% |
| 2018-12-31 | $4.20 Billion | +18.83% |
| 2017-12-31 | $3.53 Billion | +11.07% |
| 2016-12-31 | $3.18 Billion | +186.47% |
| 2015-12-31 | $1.11 Billion | +118.93% |
| 2014-12-31 | $507.12 Million | -- |